Retrieve available abstracts of 360 articles: HTML format
Single Articles
June 2025
SHOGRY FF, Hayes KN, Kim S, Burden AM, et al The rise and fall of raloxifene use for osteoporosis, 1999-2022.
Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07544. PubMedAbstract available
MARSELOU E, Kelekis A, Dimitriadis Z, Koumantakis GA, et al Risk factors for refracture or new vertebral compression fractures after
percutaneous vertebroplasty: a systematic review and meta-analysis.
Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07523. PubMedAbstract available
SON HJ, Park SJ, Park JS, Han K, et al Impact of smoking, diabetes, and exercise on dementia risk in women with
osteoporosis: a nationwide cohort study.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07524. PubMedAbstract available
TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al Authors' response to 01460, renal dysfunction and its influence on osteoporosis
treatment outcomes: a critical review of recent findings.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-024-07293. PubMed
CHEN J, Zhou Q, Yu W, Cao D, et al Renal dysfunction and its influence on osteoporosis treatment outcomes: a
critical review of recent findings.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07534. PubMed
ZHANG Y, Ma M, Huang X, Liu J, et al Machine learning is changing osteoporosis detection: an integrative review.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07541. PubMedAbstract available
BUGBIRD AR, Matheson BE, Walle M, Neeteson NJ, et al Quantifying localized bone loss in clinical computed tomography using void
spaces.
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07558. PubMedAbstract available
CIROVIC A, Milovanovic P Can adjustment for iron, zinc, and calcium levels clarify the relationship
between blood cadmium and bone mineral density?
Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07434. PubMed
HUANG CF, Ho CJ, Lin SY, Hwang JS, et al Asia-Pacific consensus for the management of osteoporosis in men.
Osteoporos Int. 2025 Jun 4. doi: 10.1007/s00198-025-07559. PubMedAbstract available
SHARAFI MH, Nazari A, Cheraghi M, Souri F, et al The link between osteoporosis and cardiovascular diseases: a review of shared
mechanisms, risk factors, and therapeutic approaches.
Osteoporos Int. 2025 Jun 2. doi: 10.1007/s00198-025-07553. PubMedAbstract available
BISCHOFF-FERRARI HA, Dawson-Hughes B, Orav JE, Ceglia L, et al Effect of calcifediol and cholecalciferol on muscle function in postmenopausal
women: a randomized controlled trial.
Osteoporos Int. 2025;36:1007-1018. PubMedAbstract available
May 2025
RIPPL M, Grupp P, Martini S, Muller K, et al Characteristics and treatment options of 272,152 geriatric patients with very
high and high fracture risk.
Osteoporos Int. 2025 May 30. doi: 10.1007/s00198-025-07540. PubMedAbstract available
CHENG R, Zhang L Case report on possible causes of severe osteoporosis: diffuse panbronchiolitis.
Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07532. PubMedAbstract available
MASHARAWI Y, Lerner A, Weisman A Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for
Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without
vertebral fractures.
Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07526. PubMedAbstract available
BERNATZ JT, Sandhu KP, Krueger D, Borchardt G, et al Trabecular bone score predicts distal femur screw pull-out strength better than
DXA bone mineral density, CT Hounsfield units, and cortical density.
Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07530. PubMedAbstract available
LI H, Wang H Association between weekend warrior physical activity pattern and bone mineral
density among adults: national health and nutrition examination survey.
Osteoporos Int. 2025 May 26. doi: 10.1007/s00198-025-07535. PubMedAbstract available
GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al Author response to: among people on osteoporosis medication, loss of appendicular
or total body lean mass is an independent risk factor for hip and major
osteoporotic fractures.
Osteoporos Int. 2025 May 23. doi: 10.1007/s00198-025-07520. PubMed
UM YJ, Cho IY, Koo HY, Park YM, et al Intellectual disabilities and risk of fractures: A population-based cohort study.
Osteoporos Int. 2025 May 13. doi: 10.1007/s00198-025-07519. PubMedAbstract available
PRAVEEN AD, Jha D, Baker A, Fleps I, et al Comparison of the time-dependent discriminatory accuracy of femoral strength and
bone mineral density for predicting future hip and major osteoporotic fractures:
a 16-year follow-up of the AGES-Reykjavik cohort.
Osteoporos Int. 2025 May 12. doi: 10.1007/s00198-025-07503. PubMedAbstract available
ORAVEC D, Yadav RN, Cushman T, Flynn MJ, et al Osteoporosis screening in the mammography setting via digital wrist
tomosynthesis.
Osteoporos Int. 2025 May 9. doi: 10.1007/s00198-025-07516. PubMedAbstract available
LIU E, Liu RY, Moraros J, McCloskey EV, et al Association between walking and hip fracture in women aged 65 and older: 20-year
follow-up from the study of osteoporotic fractures.
Osteoporos Int. 2025 May 7. doi: 10.1007/s00198-025-07508. PubMedAbstract available
WU Q, Jung J Precision fracture risk assessment: leveraging genomic and clinical data for
personalized care.
Osteoporos Int. 2025 May 6. doi: 10.1007/s00198-025-07517. PubMed
OUYANG W, Guo G, Zhao C Comment on: The Healing and therapeutic effects of perioperative bisphosphonate
use in patients with fragility fractures: meta-analysis of 19 clinical trials.
Osteoporos Int. 2025 May 2. doi: 10.1007/s00198-025-07430. PubMed
April 2025
HOUEL V, Marchasson G, Ramdane N, Philippoteaux C, et al Patients with periprosthetic femoral fractures are older adults who are commonly
diagnosed with osteoporosis.
Osteoporos Int. 2025 Apr 29. doi: 10.1007/s00198-025-07486. PubMedAbstract available
ALBRECHT AP, Kistler-Fischbacher M, De Godoi Rezende Costa Molino C, Armbrecht G, et al Prevalence and incidence of osteoporotic vertebral fractures in
community-dwelling European older adults: an observational analysis of the
DO-HEALTH trial.
Osteoporos Int. 2025 Apr 25. doi: 10.1007/s00198-025-07489. PubMedAbstract available
ADAMS H, Salman L, Drinkwater KJ, Griffin J, et al Improved radiological diagnosis of osteoporotic vertebral fragility fractures
following UK-wide interventions and re-audit-can this be maintained and
translated into clinical practice?
Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07488. PubMedAbstract available
PIGNOLO RJ, Connell JJ, Briggs W, Kelly CJ, et al Opportunistic assessment of osteoporosis using hip and pelvic X-rays with
OsteoSight: validation of an AI-based tool in a US population.
Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07487. PubMedAbstract available
GORGEY AS, Venigalla S, Deitrich JN, Ballance WB, et al Electrical stimulation paradigms on muscle quality and bone mineral density after
spinal cord injury.
Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07482. PubMedAbstract available
IFTIKHAR QUA Bridging the gap: validating AI for real-world osteoporosis screening.
Osteoporos Int. 2025 Apr 15. doi: 10.1007/s00198-025-07496. PubMed
ORHADJE E, Makaram N, Berg K, Hauser B, et al Clinical presentation, risk factors and management of pregnancy-associated
osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2025 Apr 9. doi: 10.1007/s00198-025-07479. PubMedAbstract available
LO HZ, Leow K, Hii R, Nerlekar N, et al Effect of osteoporosis medications on vascular and valvular calcification: a
systematic review and meta-analysis.
Osteoporos Int. 2025 Apr 7. doi: 10.1007/s00198-025-07468. PubMedAbstract available
LI J, Fu X, Shi H, Jing J, et al Protective role of irisin on bone in osteoporosis: a systematic review of rodent
studies.
Osteoporos Int. 2025 Apr 7. doi: 10.1007/s00198-025-07470. PubMedAbstract available
BAUMANN AN, Krez AN, Trager RJ, Anaspure OS, et al Osteoporosis is not associated with increased reoperation or fracture risk three
years after total ankle arthroplasty: a retrospective cohort study.
Osteoporos Int. 2025 Apr 4. doi: 10.1007/s00198-025-07473. PubMedAbstract available
HAYES KN, Zullo AR, Berry SD, Oganisian A, et al Osteoporosis medication use over time in the United States and Canada.
Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07484. PubMedAbstract available
LIU L, Wang Y, Tan B, Huang P, et al Association of beta-adrenergic receptor blockers use with the risk of fracture in
adults: a systematic review and meta-analysis.
Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07471. PubMedAbstract available
GATINEAU G, Hind K, Shevroja E, Gonzalez-Rodriguez E, et al Advancing trabecular bone score (TBS): clinical performance of TBS version 4.0
with direct correction for soft tissue thickness-the osteolaus study.
Osteoporos Int. 2025;36:715-724. PubMedAbstract available
KHAN AA, AbuAlrob H, Ali DS, Al Kassem Z, et al Skeletal health status among patients with chronic hypoparathyroidism: results
from the Canadian National Hypoparathyroidism Registry (CNHR).
Osteoporos Int. 2025;36:673-684. PubMedAbstract available
VARENNA M, Zucchi F, Di Taranto R, Orsini F, et al Osteoclast in CRPS: an alleged guilty fully acquitted.
Osteoporos Int. 2025;36:737-740. PubMedAbstract available
PATINO-SALAZAR JD, Ovejero D, Gabernet M, Martinez-Gil N, et al Identifying rare variants in genes related to bone phenotypes in a cohort of
postmenopausal women.
Osteoporos Int. 2025;36:637-644. PubMedAbstract available
WOLF JVE, Schoene D, Kohl M, Kemmler W, et al Effects of combined protein and exercise interventions on bone health in
middle-aged and older adults - A systematic literature review and meta-analysis
of randomized controlled trials.
Osteoporos Int. 2025;36:609-625. PubMedAbstract available
March 2025
BHATTOA HP, Vasikaran S, Trifonidi I, Kapoula G, et al Update on the role of bone turnover markers in the diagnosis and management of
osteoporosis: a consensus paper from The European Society for Clinical and
Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
(ESCEO), Internatio
Osteoporos Int. 2025 Mar 28. doi: 10.1007/s00198-025-07422. PubMedAbstract available
PAN Y, Wan Y, Wang Y, Yu T, et al Conventional chest computed tomography-based radiomics for predicting the risk of
thoracolumbar osteoporotic vertebral fractures.
Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-024-07338. PubMedAbstract available
MARKARIAN AM, Taaffe DR, Bettariga F, Luo H, et al Bone mineral density in childhood cancer survivors during and after oncological
treatment: A systematic review and meta-analysis.
Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-025-07458. PubMedAbstract available
BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al Correction: PTH1 receptor agonists for fracture risk: a systematic review and
network meta-analysis.
Osteoporos Int. 2025 Mar 26. doi: 10.1007/s00198-025-07452. PubMed
SOPINA L, Hitz MF, Thygesen LC, Langdahl B, et al Healthcare and productivity cost of osteoporosis: a Danish register-based
quasi-experimental study.
Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07453. PubMedAbstract available
GERDHEM P, Wihlborg A, Bergstrom IB Site-specific volumetric skeletal changes in women with and without a distal
forearm fracture: a case-control study with a mean 7-year follow-up.
Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07412. PubMedAbstract available
SHAHZAD UB, Hanif U, Aiman U From bisphosphonates to advanced therapies: a critical review of osteoporosis
treatment strategies.
Osteoporos Int. 2025 Mar 19. doi: 10.1007/s00198-025-07457. PubMed
YUKISHIMA T, Ebina K, Etani Y, Noguchi T, et al Author response to letter to the editor, (OSIN-D-25-00227) "From bisphosphonates
to advanced therapies: a critical review of osteoporosis treatment strategies".
Osteoporos Int. 2025 Mar 19. doi: 10.1007/s00198-025-07466. PubMed
PARK JH, Kwon O, Choi JH, Yeom JS, et al Perioperative teriparatide for preventing proximal junctional kyphosis and
failure in patients with osteoporosis after adult thoracolumbar spinal deformity
surgery: a prospective randomized controlled trial.
Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07449. PubMedAbstract available
STARUP-LINDE J, Stoy J, Grinderslev PB, Langdahl B, et al Prevalence and risk factors for osteoporosis in type 1 diabetes-results from an
observational study.
Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07443. PubMedAbstract available
GHASEMINEJAD-RAEINI A, Hoveidaei AH, Zarepour F, Taghavi SP, et al Notable lacking of bone mineral density measurement in cushing syndrome: a
nationwide study based on the US insurance claim database.
Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07418. PubMedAbstract available
PARK JW, Kim HY, Kim KM, Kim J, et al Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide
retrospective cohort study (2006-2022).
Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07429. PubMedAbstract available
BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al PTH1 receptor agonists for fracture risk: a systematic review and network
meta-analysis.
Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07440. PubMedAbstract available
ZHANG Q, Gao W, Xu X, Cui R, et al Elevated baseline CTX levels predict enhanced therapeutic efficacy of zoledronic
acid in augmenting lumbar spine bone mineral density among Chinese osteoporosis
patients.
Osteoporos Int. 2025 Mar 4. doi: 10.1007/s00198-025-07448. PubMedAbstract available
ENRIQUE LR, Francisco TN, Inigo EF, Cristina OT, et al Evidence-based joint statement position of perioperative bone optimization in the
arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS,
SEIOMM.
Osteoporos Int. 2025;36:375-389. PubMedAbstract available
ZHOU K, Zhu Y, Luo X, Yang S, et al A novel hybrid deep learning framework based on biplanar X-ray radiography images
for bone density prediction and classification.
Osteoporos Int. 2025;36:521-530. PubMedAbstract available
LAURSEN N, Solling AS, Harslof T, Langdahl B, et al Clinical experience with denosumab discontinuation.
Osteoporos Int. 2025;36:435-446. PubMedAbstract available
February 2025
PETERSEN TG, Rubin KH, Javaid MK, Hermann AP, et al Long-term adherence to anti-osteoporosis medication and determinants of adherence
in the population-based screening trial ROSE.
Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07436. PubMedAbstract available
LIU J, Zhang Y, Yu W, Sun L, et al TBS as a complementary tool for assessing vertebral fractures and spinal
deformity in children and adolescents with osteogenesis imperfecta.
Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07423. PubMedAbstract available
KANIS JA, Johansson H, McCloskey EV, Liu E, et al Rheumatoid arthritis and subsequent fracture risk: an individual person
meta-analysis to update FRAX.
Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-025-07397. PubMedAbstract available
ONTAN MS, Isik AT Author response to: OSIN-D-24-01894 comment on "Osteoporosis in older patients
with idiopathic normal pressure hydrocephalus".
Osteoporos Int. 2025 Feb 12. doi: 10.1007/s00198-025-07387. PubMed
MO S, Gu Y Comment on "Osteoporosis in older patients with idiopathic normal pressure
hydrocephalus".
Osteoporos Int. 2025 Feb 11. doi: 10.1007/s00198-025-07416. PubMed
CHEN R, Gong K, Chen W, Chen Z, et al Author response to: OSIN-D-24-01898: Comment on "Association of serum alkaline
phosphatase levels with bone mineral density, osteoporosis prevalence, and
mortality in US adults with osteoporosis: evidence from NHANES 2005-2018".
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07388. PubMed
SHAO J, Zhang H, Fei Q Comment on "Association of serum alkaline phosphatase levels with bone mineral
density, osteoporosis prevalence, and mortality in US adults with osteoporosis:
evidence from NHANES 2005-2018".
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07417. PubMed
LO JC, Chandra M, Khan MM, Barzilay J, et al Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a
single US integrated healthcare system.
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-024-07372. PubMedAbstract available
MAKKAR B, Obremskey W, Avidano R, Ott S, et al The definition of atypical femoral fractures should include periprosthetic
femoral fractures (PAFFs).
Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07401. PubMedAbstract available
NAKAJIMA K, Horii C, Kodama H, Shirokoshi T, et al Association between vertebral fractures and brain volume: insights from a
community cohort study.
Osteoporos Int. 2025 Feb 5. doi: 10.1007/s00198-025-07403. PubMedAbstract available
TICINESI A, Siniscalchi C, Meschi T, Nouvenne A, et al Gut microbiome and bone health: update on mechanisms, clinical correlations, and
possible treatment strategies.
Osteoporos Int. 2025;36:167-191. PubMedAbstract available
BINKLEY N, Sempos CT, Borchardt G, Larsen J, et al Association of standardized serum 25-hydroxyvitamin D with falls in
post-menopausal women.
Osteoporos Int. 2025;36:255-264. PubMedAbstract available
January 2025
NOOR A, Nabi R, Khan HT, Noor A, et al Bridging the gap: enhancing osteoporosis management through AI-driven predictive
models.
Osteoporos Int. 2025 Jan 29. doi: 10.1007/s00198-025-07396. PubMed
KAWAMURA K, Murata S, Kitano Y, Mera Y, et al Metaphyseal comminution in distal radius fractures: a predictor of secondary
fragility fractures and the role of osteoporosis treatment.
Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07404. PubMedAbstract available
NASO CM, Lin SY, Song G, Xue H, et al Time trend analysis of osteoporosis prevalence among adults 50 years of age and
older in the USA, 2005-2018.
Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07395. PubMedAbstract available
BROOKS ELG, Tangney CC, Ritz EM Ultra-processed food intake and prevalence of osteoporosis in US adults aged
50 years and older: a cross-sectional analysis.
Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07394. PubMedAbstract available
PATRA S Response to the letter "OSIN-24-D-01312, letter to the editor commenting on
'evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in
pheochromocytoma and paraganglioma; a multi-centric case-control study from
India'".
Osteoporos Int. 2025 Jan 23. doi: 10.1007/s00198-024-07354. PubMed
YUKISHIMA T, Ebina K, Etani Y, Noguchi T, et al Impact of switching from bisphosphonates to denosumab, teriparatide, or
romosozumab in patients with postmenopausal osteoporosis: a case-control study.
Osteoporos Int. 2025 Jan 16. doi: 10.1007/s00198-025-07386. PubMedAbstract available
LI X, Cheng L The clinical trial landscape of anti-RANKL agents for osteoporosis: current
status and future directions.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07389. PubMed
DURBIN JW, Zhao AY, Cui E, Agarwal AR, et al Trends in screening and treatment of osteoporosis after periprosthetic fractures
from 2010 to 2020.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07385. PubMedAbstract available
LIU Z, Tian M, Duan L Enhancing emergency management for osteoporotic patients: a commentary on
physical activity and mortality insights.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-024-07371. PubMed
LEE S, Hong N, Cho SJ, Shin S, et al Effect of romosozumab on bone mineral density and trabecular bone score in
premenopausal women with low bone mass.
Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-024-07336. PubMedAbstract available
ANDREASEN C, Dahl C, Frihagen F, Borgen TT, et al Fracture liaison service (FLS) is associated with lower subsequent fragility
fracture risk and mortality: NoFRACT (the Norwegian capture the fracture
initiative).
Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-024-07376. PubMedAbstract available
IKI M, Fujimori K, Okimoto N, Nakatoh S, et al Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in
fracture risk after the discontinuation of long-term oral glucocorticoid therapy:
a retrospective cohort study using a nationwide health insurance claims database
in Japan.
Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-025-07383. PubMed
HUANG Z, Liao TC, Chuang AT, Shao SC, et al Denosumab and clinical outcomes among men with osteoporosis: a retrospective
cohort study.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07381. PubMedAbstract available
CAO D, Cao Z, Liu A Comment on: Rapid reduction in fracture risk after the discontinuation of
long-term oral glucocorticoid therapy: a retrospective cohort study using a
nationwide health insurance claims database in Japan.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07374. PubMed
CHEN F, Luo J, Li L The association between blood cadmium levels and bone mineral density in U.S.
adolescents aged 12-19 years.
Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07349. PubMedAbstract available
BUGBIRD AR, Boisvert NMJ, Burt LA, Boyd SK, et al Choose your mother wisely: the familial resemblance of bone adaptation.
Osteoporos Int. 2025;36:141-149. PubMedAbstract available
December 2024
RAMSCHUTZ C, Sollmann N, El Husseini M, Kupfer K, et al Cervicothoracic volumetric bone mineral density assessed by opportunistic QCT may
be a reliable marker for osteoporosis in adults.
Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07373. PubMedAbstract available
ALHARTHY A Assessment of trabecular bone Hounsfield units in the lumbar spine for
osteoporosis evaluation in individuals aged 65 and above: a review.
Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07340. PubMedAbstract available
YUE X, Shi S Error in Mendelian randomization analysis in "Higher risk of osteoporosis in
adult-onset asthma than childhood-onset asthma".
Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07344. PubMed
LIN YC, Chiang PH, Huang JY, Wu WS, et al Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin
modulator users.
Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07356. PubMedAbstract available
NAGENDRA L, Chandran M, Reginster JY, Bhadada SK, et al Cost-effectiveness of FRAX(R)-based intervention thresholds for management of
osteoporosis in Indian women: a Markov microsimulation model analysis.
Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07328. PubMedAbstract available
BLAKE RJ, Melemai VK, Fitzpatrick BM, Hubbard DF, et al Bilateral femoral neck fractures in pregnancy suggestive of transient
osteoporosis of the hip in a patient with hyperparathyroidism: a case report.
Osteoporos Int. 2024 Dec 24. doi: 10.1007/s00198-024-07346. PubMedAbstract available
YOEL U, Alkobi Weiss H, Goldbart A, Silverman Siris E, et al The impact of a fracture liaison service with in-hospital anti-osteoporosis
treatment on subsequent hip fracture and mortality rates-a single-center
retrospective study.
Osteoporos Int. 2024 Dec 18. doi: 10.1007/s00198-024-07325. PubMedAbstract available
CAO D, Chen J, Yu W Comment on: Among people on osteoporosis medication, loss of appendicular or
total body lean mass is an independent risk factor for hip and major osteoporotic
fractures.
Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07306. PubMed
ERDEN Y, Temel MH, Bagcier F Author response to: OSIN-D-24-00381, artificial intelligence insights into
osteoporosis.
Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07323. PubMed
PARK HJ, Kim MG, Yoo YS, Lee B, et al Correction: determination of the combined effects of asian herbal medicine with
calcium and/or vitamin D supplements on bone mineral density in primary
osteoporosis: a systematic review and meta-analysis.
Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07335. PubMed
SONI M, Shabil M, Sah S Comment on "Association of proton-density fat fraction with osteoporosis: a
systematic review and meta-analysis".
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07350. PubMed
IKI M, Fujimori K, Okimoto N, Nakatoh S, et al Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in
fracture risk after the discontinuation of long-term oral glucocorticoid therapy:
a retrospective cohort study using a nationwide health insurance claims database
in Japan
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07332. PubMed
VAN OOSTWAARD M, van den Bergh JP, Wyers CE Author response to 01530, Proactive strategies for fracture risk in androgen
deprivation therapy: a call for multidisciplinary collaboration.
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07322. PubMed
RAZA MH, Bhutta ME, Siddique MH Proactive strategies for fracture risk in androgen deprivation therapy: a call
for multidisciplinary collaboration.
Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07330. PubMed
NARLA RR, Adler RA Rationale for osteoporosis screening in men.
Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07337. PubMedAbstract available
KIM CH, Kim K, Kim JW The effect of denosumab on minimum 3-years BMD changes in patients with
osteoporotic hip fractures: a propensity score matching analysis.
Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07314. PubMedAbstract available
IKI M, Fujimori K, Okimoto N, Nakatoh S, et al Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in
fracture risk after the discontinuation of long-term oral glucocorticoid therapy:
a retrospective cohort study using a nationwide health insurance claims database
in Japan.
Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07333. PubMed
GU C, Cui Y Comment on: Rapid reduction in fracture risk after the discontinuation of
long-term oral glucocorticoid therapy: a retrospective cohort study using a
nationwide health insurance claims database in Japan.
Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07327. PubMed
SALMORAL A, Peris P, Lopez Medina C, Florez H, et al Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.
Osteoporos Int. 2024 Dec 3. doi: 10.1007/s00198-024-07309. PubMedAbstract available
PASQUINUCCI E, Limardo M, Salerno FR, Luise CM, et al Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two
case reports.
Osteoporos Int. 2024;35:2231-2234. PubMedAbstract available
MARTIN DP 2ND, Lake S, Behun M, Krueger D, et al Intraoperative physician assessment during total hip arthroplasty correlates with
DXA parameters.
Osteoporos Int. 2024;35:2145-2151. PubMedAbstract available
TSAI JN, Jordan M, Lee H, Leder BZ, et al One versus 2 years of alendronate following denosumab: the CARD extension.
Osteoporos Int. 2024;35:2225-2230. PubMedAbstract available
RATHMANN W, Kostev K Type 2 diabetes incidence in patients initiating denosumab or alendronate
treatment: a primary care cohort study.
Osteoporos Int. 2024;35:2099-2106. PubMedAbstract available
November 2024
CHEN R, Gong K, Chen W, Chen Z, et al Association of serum alkaline phosphatase levels with bone mineral density,
osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence
from NHANES 2005-2018.
Osteoporos Int. 2024 Nov 29. doi: 10.1007/s00198-024-07324. PubMedAbstract available
AZAD TD, Wu RJ, Anderson KE, Darden M, et al Osteoporosis testing and treatment remain low in both Traditional Medicare and
Medicare Advantage.
Osteoporos Int. 2024 Nov 21. doi: 10.1007/s00198-024-07318. PubMedAbstract available
ONTAN MS, Cam Mahser A, Dost FS, Isik AT, et al Osteoporosis in older patients with idiopathic normal pressure hydrocephalus.
Osteoporos Int. 2024 Nov 18. doi: 10.1007/s00198-024-07317. PubMedAbstract available
DE BRUIN IJA, Wyers CE, Vranken L, Schousboe JT, et al Systematic evaluation of abdominal aortic calcification in patients with a recent
clinical fracture visiting the Fracture Liaison Service.
Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07288. PubMedAbstract available
DAUNGSUPAWONG H, Wiwanitkit V Artificial intelligence insights into osteoporosis: comment.
Osteoporos Int. 2024 Nov 7. doi: 10.1007/s00198-024-07102. PubMed
October 2024
EVERTS-GRABER J, Reichenbach S, Lehmann T Response to the Letter to the Editor regarding "The effect of romosozumab on bone
mineral density depending on prior treatment: a prospective, multicentre cohort
study in Switzerland" by Yang and colleagues.
Osteoporos Int. 2024 Oct 28. doi: 10.1007/s00198-024-07282. PubMed
YANG J, Cao D, Liu A Letter to the Editor Regarding "The effect of romosozumab on bone mineral density
depending on prior treatment: a prospective, multicentre cohort study in
Switzerland".
Osteoporos Int. 2024 Oct 28. doi: 10.1007/s00198-024-07281. PubMed
CAO D, Gu N, Liu A Comment on: Low-dose glucocorticoid increase the risk of fracture in
postmenopausal women with low bone mass: a retrospective cohort study.
Osteoporos Int. 2024 Oct 23. doi: 10.1007/s00198-024-07248. PubMed
ADESINA OO, Jenkins IC, Galvao F, de Moura AC, et al Alendronate preserves bone mineral density in adults with sickle cell disease and
osteoporosis.
Osteoporos Int. 2024 Oct 22. doi: 10.1007/s00198-024-07268. PubMedAbstract available
ZHOU K, Li R, Wang J Letter to the editor concerning "Sex differences in hemoglobin levels and
five-year refracture risk in patients with osteoporotic fractures: a
retrospective cohort analysis".
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07287. PubMed
HIRATA RP, Thomsen MJ, Liston M, Christensen MG, et al Letter to editor: rebuttal to OSIN-D-24-01254 "RE: Clinical features of fallers
and non-fallers: Finding best-performing combinations of physical performance
measurements to discriminate physical impairments between fallers and non-fallers
among older
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07257. PubMed
DAUNGSUPAWONG H, Wiwanitkit V RE: Clinical features of fallers and non-fallers: Finding best-performing
combinations of physical performance measurements to discriminate physical
impairments between fallers and non-fallers among older adults with and without
osteoporosis.
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07256. PubMed
SHARMA M, Beaudart C, Clark P, Fujiwara S, et al Clinical and demographic factors determining patient fracture risk decision point
(FRDP): The improving risk communication in osteoporosis (RICO) project.
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07264. PubMedAbstract available
IKI M, Fujimori K, Okimoto N, Nakatoh S, et al Rapid reduction in fracture risk after the discontinuation of long-term oral
glucocorticoid therapy: a retrospective cohort study using a nationwide health
insurance claims database in Japan.
Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07284. PubMedAbstract available
CARDINALI DP, Reiter RJ Clinical use of melatonin in osteoporosis: Expectations still unmet.
Osteoporos Int. 2024 Oct 18. doi: 10.1007/s00198-024-07261. PubMed
PERSSON R, Hagberg KW, Pranschke E, Vasilakis-Scaramozza C, et al Treatment for osteoporosis and risk of osteonecrosis of the jaw among female
patients in the United Kingdom Clinical Practice Research Datalink.
Osteoporos Int. 2024 Oct 14. doi: 10.1007/s00198-024-07262. PubMedAbstract available
DU J, Cui H, Zhao Y, Xue H, et al Correction: Exposure to air pollution might decrease bone mineral density and
increase the prevalence of osteoporosis: A mendelian randomization study.
Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07271. PubMed
CHEN H, Lou Y, Fei S, Luo J, et al Association between physical activity and mortality in patients with
osteoporosis: a cohort study of NHANES.
Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07280. PubMedAbstract available
BORGSTROM F, Lorentzon M, Johansson H, Harvey NC, et al Cost-effectiveness intervention thresholds for romosozumab and teriparatide in
the treatment of osteoporosis in the UK.
Osteoporos Int. 2024 Oct 4. doi: 10.1007/s00198-024-07251. PubMedAbstract available
AWAN EF, Farooqi HA, Nabi R Advancing bone health strategies in Duchenne muscular dystrophy: the role of BMD
monitoring in transforming prognosis.
Osteoporos Int. 2024;35:1865-1866. PubMed
DENG X, Wu X, Sun Z, Liu Q, et al Associations between new obesity indices and abnormal bone density in type 2
diabetes mellitus patients.
Osteoporos Int. 2024;35:1807-1815. PubMedAbstract available
September 2024
TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al Association between renal function and fracture incidence during treatment with
teriparatide or alendronate: an exploratory subgroup analysis of the Japanese
Osteoporosis Intervention Trial-05.
Osteoporos Int. 2024 Sep 30. doi: 10.1007/s00198-024-07260. PubMedAbstract available
GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al Among people on osteoporosis medication, loss of appendicular or total body lean
mass is an independent risk factor for hip and major osteoporotic fractures.
Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07240. PubMedAbstract available
MASUDA S, Fukasawa T, Matsuda S, Yoshida S, et al Comparative effectiveness and cardiovascular safety of romosozumab versus
teriparatide in patients with osteoporosis: a population-based cohort study.
Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07255. PubMedAbstract available
DU J, Cui H, Zhao Y, Xue H, et al Exposure to air pollution might decrease bone mineral density and increase the
prevalence of osteoporosis: a Mendelian randomization study.
Osteoporos Int. 2024 Sep 23. doi: 10.1007/s00198-024-07249. PubMedAbstract available
CAMPISI G, Mauceri R, Coppini M, Bedogni A, et al Correction: Letter to Editor regarding "Why are osteoporosis patients treated
with antiresorptive therapies considered like oncology patients regarding their
oral health care?".
Osteoporos Int. 2024 Sep 18. doi: 10.1007/s00198-024-07245. PubMed
ZHAO AS, Liu Y, Mulvey JJ, Tchang BG, et al Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and
romosozumab: a case report.
Osteoporos Int. 2024 Sep 17. doi: 10.1007/s00198-024-07243. PubMedAbstract available
GHASEMINEJAD-RAEINI A, Azarboo A, Zareshahi N, Jalali S, et al Early-life famine exposure and risk of osteoporosis and low bone mineral density:
a systematic review and meta-analysis.
Osteoporos Int. 2024 Sep 13. doi: 10.1007/s00198-024-07250. PubMedAbstract available
ARMUTCU F, McCloskey E Insulin resistance, bone health, and fracture risk.
Osteoporos Int. 2024 Sep 12. doi: 10.1007/s00198-024-07227. PubMedAbstract available
JAIN RK Comment on article "Race-specific FRAX models are evidence-based and support
equitable care: a response to the ASBMR Task Force Report on Clinical Algorithms
for Fracture Risk".
Osteoporos Int. 2024 Sep 4. doi: 10.1007/s00198-024-07242. PubMed
MAHMUD M, Muscatello DJ, Rahman MB, Osborne NJ, et al Association between socioeconomic deprivation and bone health status in the UK
biobank cohort participants.
Osteoporos Int. 2024;35:1573-1584. PubMedAbstract available
August 2024
LIN CJ, Liu SJ, Lin KY Author response to OSIN-D-24-00958 comment on: the association between myasthenia
gravis and risk of fracture: a systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07201. PubMed
LI J, Zheng J Comment on: The association between myasthenia gravis and risk of fracture: a
systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07200. PubMed
HIRATA RP, Thomsen MJ, Liston M, Christensen MG, et al Clinical features of fallers and non-fallers: finding best-performing
combinations of physical performance measurements to discriminate physical
impairments between fallers and non-fallers among older adults with and without
osteoporosis.
Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07233. PubMedAbstract available
FAN Z, Zhao J, Chen J, Hu W, et al Causal associations of osteoporosis with stroke: a bidirectional Mendelian
randomization study.
Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07235. PubMedAbstract available
KHADIVI G, Akhtari A, Sharifi F, Zargarian N, et al Diagnostic accuracy of artificial intelligence models in detecting osteoporosis
using dental images: a systematic review and meta-analysis.
Osteoporos Int. 2024 Aug 23. doi: 10.1007/s00198-024-07229. PubMedAbstract available
CAMPISI G, Mauceri R, Coppini M, Bedogni A, et al Author Response to Letter to Editor regarding "Why are osteoporosis patients
treated with antiresorptive therapies considered like oncology patients regarding
their oral health care?".
Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07192. PubMed
TRAN TS, Bliuc D, Blank RD, Center JR, et al Fracture risk assessment in the presence of competing risk of death.
Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07224. PubMedAbstract available
TAO J, Li H, Wang H, Tan J, et al Metabolic dysfunction-associated fatty liver disease and osteoporosis: the
mechanisms and roles of adiposity.
Osteoporos Int. 2024 Aug 13. doi: 10.1007/s00198-024-07217. PubMedAbstract available
YUAN K, Liu Q, Luo P, Wang C, et al Association of proton-density fat fraction with osteoporosis: a systematic review
and meta-analysis.
Osteoporos Int. 2024 Aug 12. doi: 10.1007/s00198-024-07220. PubMedAbstract available
MCCARROLL K, Fitzpatrick D, Lannon R Comment on: A novel sequential treatment approach between denosumab and
romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07218. PubMed
KUMAR S, Gild ML, McDonald MM, Kim AS, et al Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment
approach between denosumab and romosozumab in patients with severe osteoporosis.
Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07214. PubMed
WANG L, Guo X, Qin J, Jin Z, et al Assessing the causal relationship between plasma proteins and osteoporosis: novel
insights into pathological mechanisms and therapeutic implications.
Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07225. PubMedAbstract available
ZENG Y, Yang Y, Wang J, Meng G, et al The Healing and therapeutic effects of perioperative bisphosphonate use in
patients with fragility fractures: meta-analysis of 19 clinical trials.
Osteoporos Int. 2024 Aug 8. doi: 10.1007/s00198-024-07191. PubMedAbstract available
HADJI P, Kamali L, Thomasius F, Horas K, et al Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference
teriparatide on bone mineral density, trabecular bone score, and bone parameters
assessed using quantitative ultrasound, 3D-SHAPER((R)) and high-resolution
peripheral co
Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07208. PubMedAbstract available
KIRK JM, Rathbun AM, Gruber-Baldini AL, Hochberg MC, et al Sex differences and predictors of anti-osteoporosis medication use in the
12 months after hip fracture surgery in adults 65 or older.
Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07211. PubMedAbstract available
HU F, Li X, Zhao D, Chen C, et al The diagnostic value of MRI-based vertebral bone quality score for osteoporosis
or osteopenia in patients undergoing lumbar surgery: a meta-analysis.
Osteoporos Int. 2024 Aug 1. doi: 10.1007/s00198-024-07190. PubMedAbstract available
KANIS JA, Dawson-Hughes B, Campusano C, Cooper C, et al IOF position on scientists and societies operating in conflict zones.
Osteoporos Int. 2024;35:1323-1328. PubMedAbstract available
July 2024
PADERNO A, Gomes EJA, Gilberg L, Maerkisch L, et al Correction to: Artificial intelligence-enhanced opportunistic screening of
osteoporosis in CT scan: a scoping Review.
Osteoporos Int. 2024 Jul 31. doi: 10.1007/s00198-024-07206. PubMed
TAYLOR L, Matsunaga M, Ahn HJ, Siu AM, et al Risk factors associated with 1-year mortality after osteoporotic hip fracture in
Hawai'i: higher mortality risk among Native Hawaiians and other Pacific
Islanders.
Osteoporos Int. 2024 Jul 30. doi: 10.1007/s00198-024-07195. PubMedAbstract available
REGINSTER JY, Czerwinski E, Wilk K, Borowy P, et al Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a
double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal
women with osteoporosis.
Osteoporos Int. 2024 Jul 23. doi: 10.1007/s00198-024-07161. PubMedAbstract available
PATRA S, Boro H, Porchezhian P, Khan N, et al Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in
pheochromocytoma and paraganglioma; a multi-centric case-control study from
India.
Osteoporos Int. 2024 Jul 22. doi: 10.1007/s00198-024-07198. PubMedAbstract available
LE HV, Van BW, Shahzad H, Teng P, et al Fracture liaison service-a multidisciplinary approach to osteoporosis management.
Osteoporos Int. 2024 Jul 18. doi: 10.1007/s00198-024-07181. PubMedAbstract available
SCHWARCZ Y, Yanover C, Rouach V, Luria S, et al Non-osteoporotic fractures are associated with increased risk of subsequent major
osteoporotic fractures.
Osteoporos Int. 2024 Jul 13. doi: 10.1007/s00198-024-07169. PubMedAbstract available
PADERNO A, Ataide Gomes EJ, Gilberg L, Maerkisch L, et al Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT
scan: a scoping Review.
Osteoporos Int. 2024 Jul 10. doi: 10.1007/s00198-024-07179. PubMedAbstract available
JOHANSSON P, Kristjansdottir HL, Johansson H, Mellstrom D, et al Increased risk of hip and major osteoporotic fractures in 8463 patients who have
undergone stem cell transplantation, a Swedish population-based study.
Osteoporos Int. 2024 Jul 8. doi: 10.1007/s00198-024-07171. PubMedAbstract available
MOBERG L, Jehpsson L, Nilsson PM, Rosengren B, et al Birth weight and birth length affect future fracture risk differently in men and
women.
Osteoporos Int. 2024 Jul 5. doi: 10.1007/s00198-024-07172. PubMedAbstract available
KANIS JA, Harvey NC, Lorentzon M, Liu E, et al Race-specific FRAX models are evidence-based and support equitable care: a
response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.
Osteoporos Int. 2024 Jul 3. doi: 10.1007/s00198-024-07162. PubMedAbstract available
BENSKY MJ, Adler L, Banon T, Gabay L, et al Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews.
Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07174. PubMed
PARK SY, Ahn SH, Bae GH, Jang S, et al Low-dose glucocorticoid increase the risk of fracture in postmenopausal women
with low bone mass: a retrospective cohort study.
Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07159. PubMedAbstract available
MCCARROLL K, Carroll T, Neville M, Fitzpatrick D, et al Delayed and significant hypercalcaemia due to teriparatide therapy: a case report
and review.
Osteoporos Int. 2024;35:1299-1302. PubMedAbstract available
June 2024
PU X, Liu B, Wang D, Xiao W, et al Opportunistic use of lumbar computed tomography and magnetic resonance imaging
for osteoporosis screening.
Osteoporos Int. 2024 Jun 28. doi: 10.1007/s00198-024-07164. PubMedAbstract available
CORDOVA LA, Gonzalez-Quintanilla D, Heymann D Why are osteoporosis patients treated with antiresorptive therapies considered
like oncology patients regarding their oral health care?
Osteoporos Int. 2024 Jun 27. doi: 10.1007/s00198-024-07173. PubMed
EVERTS-GRABER J, Wenger M, Oser S, Studer U, et al The effect of romosozumab on bone mineral density depending on prior treatment: a
prospective, multicentre cohort study in Switzerland.
Osteoporos Int. 2024 Jun 26. doi: 10.1007/s00198-024-07155. PubMedAbstract available
HOLVIK K, Dahl C, Samuelsen SO, Sogaard AJ, et al Educational gradient in hip fracture incidence in Norway. The Norwegian
Epidemiologic Osteoporosis Studies (NOREPOS).
Osteoporos Int. 2024 Jun 25. doi: 10.1007/s00198-024-07133. PubMedAbstract available
BARZILAY JI, Buzkova P, Bielinski SJ, Cotch MF, et al The association of microvascular disease and endothelial dysfunction with
vertebral trabecular bone mineral density : The MESA study.
Osteoporos Int. 2024 Jun 24. doi: 10.1007/s00198-024-07152. PubMedAbstract available
MUZZAMMIL M, Bhura S, Hussain AS, Bashir S, et al Undiagnosed vertebral fragility fractures in patients with distal radius
fragility fractures: an opportunity for prevention of morbimortality in
osteoporotic patients in developing countries.
Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07149. PubMedAbstract available
SO E, Juels C, Scott RT, Sietsema DL, et al A comparison of foot fractures relative to other fragility fractures: a review
and analysis of the American Orthopaedic Association's Own the Bone Database.
Osteoporos Int. 2024 Jun 18. doi: 10.1007/s00198-024-07153. PubMedAbstract available
XU MZ, Lu K, Ye YW, Xu SM, et al Sex differences in hemoglobin levels and five-year refracture risk in patients
with osteoporotic fractures: a retrospective cohort analysis.
Osteoporos Int. 2024 Jun 6. doi: 10.1007/s00198-024-07142. PubMedAbstract available
KUMAR S, Gild ML, McDonald MM, Kim AS, et al A novel sequential treatment approach between denosumab and romosozumab in
patients with severe osteoporosis.
Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07139. PubMedAbstract available
LAROSE G, Al-Azazi S, Lix LM, Bohm E, et al Introduction of an order set after hip fracture improves osteoporosis medication
initiation and persistence: a population-based before-after analysis.
Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07131. PubMedAbstract available
TAHMASBI F, Sadoughi F, Sheikhtaheri A, Zabihiyeganeh M, et al Developing fracture liaison service framework based on comparative analysis and
scoping review.
Osteoporos Int. 2024 Jun 3. doi: 10.1007/s00198-024-07091. PubMedAbstract available
PLAIS N, Gallego-Bustos J, Mahillo-Fernandez I, Tome-Bermejo F, et al Letter to the editor.
Osteoporos Int. 2024;35:1105-1106. PubMed
GUO DM, Weng YZ, Yu ZH, Li SH, et al Semi-automatic proximal humeral trabecular bone density assessment tool:
technique application and clinical validation.
Osteoporos Int. 2024;35:1049-1059. PubMedAbstract available
ZHOU L, Zhou H, Xu H, Sun X, et al Different bone health progression patterns and early-stage risk marker in
glucocorticoid-treated ambulatory Duchenne muscular dystrophy.
Osteoporos Int. 2024;35:997-1005. PubMedAbstract available
May 2024
DENG L, Shuai P, Liu Y, Yong T, et al Diagnostic performance of radiomics for predicting osteoporosis in adults: a
systematic review and meta-analysis.
Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07136. PubMedAbstract available
PARK YB, Kim M, Nam HC, Jeon JW, et al Total knee arthroplasty and periprosthetic distal femoral fracture: looking
beyond the osteoporosis to previous osteoporotic fracture.
Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07138. PubMedAbstract available
KNIGHT KJ, Fordham RJ, Crabtree NJ, Knapp KM, et al Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis
prescription trends in England 2019-2023.
Osteoporos Int. 2024 May 25. doi: 10.1007/s00198-024-07120. PubMedAbstract available
CHEN Y, Miao Y, Zhang Q Association of combined healthy lifestyle factors with incident osteoporosis in
patients with and without type 2 diabetes.
Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07126. PubMedAbstract available
YUE YS, Liu Y, Lu K, Shi Q, et al Outdoor walking, genetic predisposition, and the risk of incident osteoporosis
among older adults: A prospective large population-based cohort study.
Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07122. PubMedAbstract available
MORENO-RABIE C, Fontenele RC, Oliveira-Santos N, Nogueira-Reis F, et al Key insights into antiresorptive drug use and osteonecrosis in osteoporotic
patients undergoing tooth extractions: A clinical and CBCT assessment.
Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07108. PubMedAbstract available
WANG X, Zhao X Letter to the Editor regarding "Associations between ultra-distal forearm bone
mineral density and incident fracture in women".
Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07098. PubMed
HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al Author Response to OSIN-D-24-00437: Letter to the Editor regarding "Associations
between ultra-distal forearm bone mineral density and incident fracture in
women".
Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07094. PubMed
ANSARI H, Jaglal S, Cheung AM, Jain R, et al Osteoporosis management in adults with schizophrenia following index hip fracture
event: a 10-year population-based retrospective cohort study, Ontario, Canada.
Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07123. PubMedAbstract available
LIN CJ, Lee YS, Yeh JH, Liu SJ, et al The association between myasthenia gravis and risk of fracture: a systematic
review and meta-analysis.
Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07097. PubMedAbstract available
ALI A, Huszti E, Noordin S, Ali U, et al Examining treatment targets and equity in bone-active medication use within
secondary fracture prevention: a systematic review and meta-analysis.
Osteoporos Int. 2024 May 14. doi: 10.1007/s00198-024-07078. PubMedAbstract available
KOBAYASHI T, Morimoto T, Ito K, Mawatari M, et al Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of
comparative safety in randomized controlled trials.
Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07118. PubMedAbstract available
KUSAKABE T, Ishihara Y, Kitamura T, Yasoda A, et al Beneficial effects of romosozumab on bone mineral density and trabecular bone
score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis
imperfecta.
Osteoporos Int. 2024 May 8. doi: 10.1007/s00198-024-07089. PubMed
XIAO X, Wu Q Enhanced fracture risk prediction: a novel multi-trait genetic approach
integrating polygenic scores of fracture-related traits.
Osteoporos Int. 2024 May 7. doi: 10.1007/s00198-024-07105. PubMedAbstract available
LIU B, Ng CY, La PBD, Wong P, et al Osteoporosis and fracture risk assessment in adults with ischaemic stroke.
Osteoporos Int. 2024 May 4. doi: 10.1007/s00198-024-07099. PubMedAbstract available
April 2024
PRAVEEN AD, Aspelund T, Ferguson SJ, Sigurethsson S, et al Refracture and mortality risk in the elderly with osteoporotic fractures: the
AGES-Reykjavik study.
Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07096. PubMedAbstract available
GOLD DT, Beckett T, Deal C, James AL, et al Treatment patterns in women with postmenopausal osteoporosis using abaloparatide:
a real-world observational study.
Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070. PubMedAbstract available
WANG M, Seibel MJ Secondary fracture prevention in primary care: a narrative review.
Osteoporos Int. 2024 Apr 23. doi: 10.1007/s00198-024-07036. PubMedAbstract available
ZUBICK P, Dahlke S Family/caregiver influence on osteoporosis management for older people: an
integrative review.
Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07081. PubMedAbstract available
AGARWAL AR, Kinnard MJ, Murdock C, Zhao AY, et al The cost-effectiveness of osteoporosis medications for preventing periprosthetic
fractures following femoral neck fracture indicated hip arthroplasty: a
break-even analysis.
Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085. PubMedAbstract available
WU J, Li J, Yan Z, Yu X, et al Higher prevalence of thyroid-specific autoantibodies (TPOAb and TgAb) is related
to a higher prevalence of fractures in females: results from NHANES 2007-2010.
Osteoporos Int. 2024 Apr 12. doi: 10.1007/s00198-024-07083. PubMedAbstract available
CHANDRAN M, Akesson KE, Javaid MK, Harvey N, et al Impact of osteoporosis and osteoporosis medications on fracture healing: a
narrative review.
Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059. PubMedAbstract available
LANE J, Langdahl B, Stone M, Kurth A, et al Romosozumab in patients who experienced an on-study fracture: post hoc analyses
of the FRAME and ARCH phase 3 trials.
Osteoporos Int. 2024 Apr 4. doi: 10.1007/s00198-024-07049. PubMedAbstract available
GIELEN E, Aldven M, Kanis JA, Borgstrom F, et al Cost-effectiveness of romosozumab for the treatment of postmenopausal women with
osteoporosis at high risk of fracture in Belgium.
Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07043. PubMedAbstract available
ANAGNOSTIS P, Lallas K, Pappa A, Avgeris G, et al The association of vasomotor symptoms with fracture risk and bone mineral density
in postmenopausal women: a systematic review and meta-analysis of observational
studies.
Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075. PubMedAbstract available
FUJITA N, Ono Y, Hashimoto K, Kawamura Y, et al Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in
sarcoidosis: a case report.
Osteoporos Int. 2024;35:733-736. PubMedAbstract available
WHITING PS, Hare K, Krueger D, Borchardt G, et al Periprosthetic fractures are osteoporotic fractures: missed opportunities for
osteoporosis diagnosis.
Osteoporos Int. 2024 Apr 1. doi: 10.1007/s00198-024-07057. PubMedAbstract available
March 2024
KOBAYASHI T, Morimoto T, Mawatari M Factors influencing the measurement of sagittal spinopelvic alignment in patients
with vertebral fractures.
Osteoporos Int. 2024 Mar 29. doi: 10.1007/s00198-024-07063. PubMed
CAI Y, Jun G, Zhuang X Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian
randomized study.
Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-023-07013. PubMedAbstract available
DANAZUMI MS, Lightbody N, Dermody G Effectiveness of fracture liaison service in reducing the risk of secondary
fragility fractures in adults aged 50 and older: a systematic review and
meta-analysis.
Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-024-07052. PubMedAbstract available
LORENTZON M, Litsne H, Axelsson KF The significance of recent fracture location for imminent risk of hip and
vertebral fractures-a nationwide cohort study on older adults in Sweden.
Osteoporos Int. 2024 Mar 23. doi: 10.1007/s00198-024-07072. PubMedAbstract available
LI D, Mao SS, Budoff MJ Trabecular bone mineral density as measured by thoracic vertebrae predicts
incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.
Osteoporos Int. 2024 Mar 22. doi: 10.1007/s00198-024-07040. PubMedAbstract available
PARK HJ, Kim MG, Yoo YS, Lee B, et al Correction to: Determination of the combined effects of asian herbal medicine
with calcium and/or vitamin D supplements on bone mineral density in primary
osteoporosis: A systematic review and meta-analysis.
Osteoporos Int. 2024 Mar 21. doi: 10.1007/s00198-024-07065. PubMed
PLUSKIEWICZ W, Tabor E The comments on manuscript entitled 'Major osteoporosis fracture prediction in
type 2 diabetes: a derivation and comparison study'.
Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07056. PubMed
DAS L, Laway BA, Sahoo J, Dhiman V, et al Bone mineral density, turnover, and microarchitecture assessed by
second-generation high-resolution peripheral quantitative computed tomography in
patients with Sheehan's syndrome.
Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07062. PubMedAbstract available
MERLIJN T, Swart KMA, Niemeijer C, van der Horst HE, et al The yield of routine laboratory examination in osteoporosis evaluation in primary
care.
Osteoporos Int. 2024 Mar 18. doi: 10.1007/s00198-024-07042. PubMedAbstract available
TAGUCHI A Letters to the Editor for "Association between dental diseases and oral hygiene
care and the risk of vertebral fracture: a nationwide cohort study".
Osteoporos Int. 2024 Mar 14. doi: 10.1007/s00198-024-07058. PubMed
PARK HJ, Kim MG, Yoo YS, Lee BR, et al Determination of the Combined Effects of Asian Herbal Medicine with Calcium
and/or Vitamin D Supplements on Bone Mineral Density in Primary Osteoporosis: A
Systematic Review and Meta-Analysis.
Osteoporos Int. 2024 Mar 13. doi: 10.1007/s00198-024-07061. PubMedAbstract available
CRANDALL CJ, Larson J, Shadyab AH, LeBoff MS, et al Physical function trajectory after wrist or lower arm fracture in postmenopausal
women: results from the Women's Health Initiative Study.
Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07050. PubMedAbstract available
HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al Associations between ultra-distal forearm bone mineral density and incident
fracture in women.
Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07041. PubMedAbstract available
CHEN L, Li C, Chen H, Xie Y, et al Cross-sectional studies of the causal link between asthma and osteoporosis:
insights from Mendelian randomization and bioinformatics analysis.
Osteoporos Int. 2024 Mar 2. doi: 10.1007/s00198-024-07037. PubMedAbstract available
February 2024
BLAY R, Flores LE, Kupzyk K, Waltman N, et al Twelve-month resistance and impact exercise program or risedronate provides a
relative benefit to hip bone structure in postmenopausal women: results from a
randomized controlled trial.
Osteoporos Int. 2024 Feb 17. doi: 10.1007/s00198-023-07008. PubMedAbstract available
PRAVEEN AD, Sollmann N, Baum T, Ferguson SJ, et al CT image-based biomarkers for opportunistic screening of osteoporotic fractures:
a systematic review and meta-analysis.
Osteoporos Int. 2024 Feb 14. doi: 10.1007/s00198-024-07029. PubMedAbstract available
ZHANG H, Yang F, Cao Z, Xu Y, et al The influence of iron on bone metabolism disorders.
Osteoporos Int. 2024;35:243-253. PubMedAbstract available
YANG Q, He J, Yuan F Improvement of proportion of days covered for denosumab under implementation of
clinical pharmacist adherence management system: normal and COVID-19 period.
Osteoporos Int. 2024;35:309-316. PubMedAbstract available
RAMCHAND SK, Tsai JN, Lee H, Sassana-Khadka G, et al The comparison of alendronate and raloxifene after denosumab (CARD) study: A
comparative efficacy trial.
Osteoporos Int. 2024;35:255-263. PubMedAbstract available
January 2024
EBINA K, Nagayama Y, Kashii M, Tsuboi H, et al An investigation of the differential therapeutic effects of romosozumab on
postmenopausal osteoporosis patients with or without rheumatoid arthritis
complications: a case-control study.
Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07019. PubMedAbstract available
YU W, Guan WM, Hayashi D, Lin Q, et al Vertebral fracture severity assessment on anteroposterior radiographs with a new
semi-quantitative technique.
Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07024. PubMedAbstract available
CUNHA-SANTOS F, Augusto D, Pinto AS, Dinis SP, et al Predictors of atypical femoral fractures: experience of a Portuguese Fracture
Liaison Service.
Osteoporos Int. 2024 Jan 29. doi: 10.1007/s00198-024-07033. PubMed
BENNETT MJ, Center JR, Perry L Establishing consensus recommendations for long-term osteoporosis care for
patients who have attended an Australian fracture liaison service: a Delphi
study.
Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07014. PubMedAbstract available
SILVA FF, Machado GR, Ribeiro ACM, Bonfiglioli KR, et al Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low
appendicular muscle mass: main risk factors for vertebral and non-vertebral
fractures in women with long-standing rheumatoid arthritis.
Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07026. PubMedAbstract available
IKI M, Fujimori K, Nakatoh S, Tamaki J, et al Average daily glucocorticoid dose, number of prescription days, and cumulative
dose in the initial 90 days of glucocorticoid therapy are associated with
subsequent hip and clinical vertebral fracture risk: a retrospective cohort study
using a nationwi
Osteoporos Int. 2024 Jan 24. doi: 10.1007/s00198-024-07023. PubMedAbstract available
JEON S, Yu D, Kim S, Kim SW, et al Comparison of radiological and functional outcomes of conservative treatment with
teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
Osteoporos Int. 2024 Jan 23. doi: 10.1007/s00198-024-07025. PubMedAbstract available
CAO X, Keyak JH, Sigurdsson S, Zhao C, et al A new hip fracture risk index derived from FEA-computed proximal femur fracture
loads and energies-to-failure.
Osteoporos Int. 2024 Jan 22. doi: 10.1007/s00198-024-07015. PubMedAbstract available
BYUN SE, Kim H, Lee SY, Kim SM, et al Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can
prevent fracture better than SERMs treatment: based on the National Health Claims
Database 2017-2019.
Osteoporos Int. 2024 Jan 19. doi: 10.1007/s00198-024-07022. PubMedAbstract available
SKJODT MK, Nicolaes J, Smith CD, Olsen KR, et al Opportunistically identifiable vertebral fractures on routine radiological
imaging predict mortality: observational cohort study.
Osteoporos Int. 2024 Jan 18. doi: 10.1007/s00198-024-07017. PubMedAbstract available
VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
Osteoporos Int. 2024 Jan 17. doi: 10.1007/s00198-023-07012. PubMedAbstract available
ZENG L, Li Y, Hong C, Wang J, et al Association between fatty liver index and controlled attenuation parameters as
markers of metabolic dysfunction-associated fatty liver disease and bone mineral
density: observational and two-sample Mendelian randomization studies.
Osteoporos Int. 2024 Jan 15. doi: 10.1007/s00198-023-06996. PubMedAbstract available
LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al Trajectories of oral bisphosphonate use after hip fractures: a population-based
cohort study.
Osteoporos Int. 2024 Jan 10. doi: 10.1007/s00198-023-06974. PubMedAbstract available
CHOO YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M, et al Health-related quality of life in osteoporosis: a systematic review of
measurement properties of the QUALEFFO-41.
Osteoporos Int. 2024 Jan 9. doi: 10.1007/s00198-023-07005. PubMedAbstract available
MULKERRIN P, O'Shea F, Fitzgerald G Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a
meta-analysis.
Osteoporos Int. 2024 Jan 8. doi: 10.1007/s00198-023-07010. PubMed
December 2023
MCCARROLL K, Fitzpatrick D, McCormack M, Abdelfadil S, et al Falsely elevated parathyroid hormone in a patient with osteoporosis: a case
report and review.
Osteoporos Int. 2023 Dec 28. doi: 10.1007/s00198-023-07006. PubMedAbstract available
CHEN H, Zhu X, Zhou Q, Pu X, et al Utility of MRI-based vertebral bone quality scores and CT-based Hounsfield unit
values in vertebral bone mineral density assessment for patients with diffuse
idiopathic skeletal hyperostosis.
Osteoporos Int. 2023 Dec 27. doi: 10.1007/s00198-023-06999. PubMedAbstract available
MAKRAS P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al Transient osteoporosis of the hip following discontinuation of denosumab and
switch to alendronate treatment.
Osteoporos Int. 2023 Dec 26. doi: 10.1007/s00198-023-07000. PubMed
DING W, Huang Y, Li G, Dong Y, et al Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma:
from genetic and prospective evidence.
Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-07004. PubMedAbstract available
MAGNO LAV, Tameirao DR, Alves LF, Guimaraes NS, et al Effect of recreational cannabis use on bone mineral density: a systematic review.
Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-06992. PubMedAbstract available
CHAVASSIEUX P, Roux JP, Chapurlat R Pre-treatment bone turnover does not influence the level of the response to
alendronate in postmenopausal osteoporosis at the bone tissue level.
Osteoporos Int. 2023 Dec 22. doi: 10.1007/s00198-023-06972. PubMedAbstract available
YOKOYAMA K, Ikeda N, Tanaka H, Ito Y, et al Changes in spinal sagittal balance after a new osteoporotic vertebral compression
fracture.
Osteoporos Int. 2023 Dec 18. doi: 10.1007/s00198-023-06976. PubMedAbstract available
YOO JE, Huh Y, Kim E, Park SH, et al Association between dental diseases and oral hygiene care and the risk of
vertebral fracture: a nationwide cohort study.
Osteoporos Int. 2023 Dec 14. doi: 10.1007/s00198-023-06983. PubMedAbstract available
GUIMARAES GC, Coelho JBC, Silva JGO, de Sant'Ana ACC, et al Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by
metabolic disturbances and its influence on bone health.
Osteoporos Int. 2023 Dec 6. doi: 10.1007/s00198-023-06991. PubMedAbstract available
HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al Geographic variation in bone mineral density and prevalent fractures in the
Canadian longitudinal study on aging.
Osteoporos Int. 2023 Dec 2. doi: 10.1007/s00198-023-06975. PubMedAbstract available
November 2023
NIZNIK JD, Kelley CJ, Fasth L, Colon-Emeric C, et al Deprescribing bisphosphonates for older adults with dementia: perspectives of
caregivers.
Osteoporos Int. 2023 Nov 18. doi: 10.1007/s00198-023-06967. PubMedAbstract available
BEAUDART C, Sharma M, Clark P, Fujiwara S, et al Patients' preferences for fracture risk communication: the Risk Communication in
Osteoporosis (RICO) study.
Osteoporos Int. 2023 Nov 13. doi: 10.1007/s00198-023-06955. PubMedAbstract available
CHEN KH, Su CM, Liu WJ, Tzeng HE, et al The joint effects of physical activity and sleep duration on risk of osteoporosis
in Taiwanese adult population: The Taiwan Biobank Study.
Osteoporos Int. 2023 Nov 10. doi: 10.1007/s00198-023-06947. PubMedAbstract available
KONNOPKA C, Buchele G, Jaensch A, Rothenbacher D, et al Evaluation of costs, osteoporosis treatment, and re-fractures in German
collaborative orthogeriatric care after fragility fractures.
Osteoporos Int. 2023 Nov 9. doi: 10.1007/s00198-023-06965. PubMedAbstract available
NAJAFI S, Mohammadkhah F, Ebrahimi MM, Harsini PA, et al Effect of educational intervention on preventing osteoporosis in postmenopausal
women.
Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06962. PubMedAbstract available
AGARWAL AR, Tarawneh O, Cohen JS, Gu A, et al The incremental risk of fragility fractures in aging men.
Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06956. PubMedAbstract available
CHEN Q, Tu Z, Ai Y, Li W, et al Forearm bone mineral density predicts screw loosening after lumbar fusion similar
to lumbar Hounsfield unit value in patients with lumbar spondylolisthesis.
Osteoporos Int. 2023 Nov 3. doi: 10.1007/s00198-023-06957. PubMedAbstract available
October 2023
HAN S, Kim S, Yeh EJ, Suh HS, et al Understanding the long-term impact of incident osteoporotic fractures on
healthcare utilization and costs in Korean postmenopausal women.
Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06934. PubMedAbstract available
INPAN R, Na Takuathung M, Sakuludomkan W, Dukaew N, et al Isoflavone intervention and its impact on bone mineral density in postmenopausal
women: a systematic review and meta-analysis of randomized controlled trials.
Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06944. PubMedAbstract available
HEUCHERT J, Koziel S, Spinek AE Radiomorphometric indices of the mandible as indicators of decreased bone mineral
density and osteoporosis - meta-analysis and systematic review.
Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06949. PubMedAbstract available
LOSCALZO E, See J, Bharill S, Yousefzadeh N, et al Growth hormone and testosterone delay vertebral fractures in boys with muscular
dystrophy on chronic glucocorticoids.
Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06951. PubMedAbstract available
KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al Correction to: Subsequent fracture risk of women with pregnancy and
lactation-associated osteoporosis after a median of 6 years of follow-up.
Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06927. PubMed
KOVACS CS Fraudulent, duplicate publication of pregnancy/lactation data in Osteoporosis
International.
Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06939. PubMed
ZERAATTALAB-MOTLAGH S, Mortazavi AS, Ghoreishy SM, Mohammadi H, et al Association between total and animal proteins with risk of fracture: A systematic
review and dose-response meta-analysis of cohort studies.
Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06948. PubMedAbstract available
PLAIS N, Bustos JG, Mahillo-Fernandez I, Tome-Bermejo F, et al Osteoporotic vertebral fractures localized in the lumbar area significantly
impact sagittal alignment.
Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06936. PubMedAbstract available
GROVLE L, Haugen AJ, Johansen M, Hasvik E, et al The terminologies of transient, migratory, or localized osteoporosis, and bone
marrow edema syndrome: a scoping review.
Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06929. PubMedAbstract available
YAN F, Wu L, Lang J, Huang Z, et al Bone density and fracture risk factors in ankylosing spondylitis: a
meta-analysis.
Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06925. PubMedAbstract available
LI N, van den Bergh JP, Boonen A, Wyers CE, et al Cost-effectiveness analysis of fracture liaison services: a Markov model using
Dutch real-world data.
Osteoporos Int. 2023 Oct 3. doi: 10.1007/s00198-023-06924. PubMedAbstract available
MAKRAS P, Yavropoulou MP, Polyzos SA, Papapoulos SE, et al The relationship between length of denosumab treatment for postmenopausal
osteoporosis and serum TRAcP5b measured six months after the last injection.
Osteoporos Int. 2023 Oct 2. doi: 10.1007/s00198-023-06931. PubMedAbstract available
OTEO-ALVARO A, Garcia CG, Sanchez AI, Santamaria CA, et al Neuropsychiatric adverse reactions in patients treated with denosumab: two case
reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
Osteoporos Int. 2023;34:1799-1804. PubMedAbstract available
BAGHERIFARD A, Hosseinzadeh A, Koosha F, Sheibani M, et al Melatonin and bone-related diseases: an updated mechanistic overview of current
evidence and future prospects.
Osteoporos Int. 2023;34:1677-1701. PubMedAbstract available
September 2023
MAAS L, Raskin N, van Onna M, Cornelissen D, et al Development and usability of a decision aid to initiate anti-osteoporosis
medication treatment in patients visiting the fracture liaison service with a
recent fracture.
Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06906. PubMedAbstract available
SOLOMON DH, Ruppert K, Cauley JA, Lian Y, et al The effect of starting metformin on bone mineral density among women with type 2
diabetes in the Study of Women's Health Across the Nation (SWAN).
Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06915. PubMedAbstract available
HUNG WC, Lin YL, Cheng TT, Chin WL, et al Establish and validate the reliability of predictive models in bone mineral
density by deep learning as examination tool for women.
Osteoporos Int. 2023 Sep 20. doi: 10.1007/s00198-023-06913. PubMedAbstract available
FUJISHIMA R, Ushimaru S, Sumi H, Aso M, et al Effect of denosumab on bone mineral density in a postmenopausal osteoporotic
woman with prolonged chronic mild hyponatremia.
Osteoporos Int. 2023 Sep 19. doi: 10.1007/s00198-023-06898. PubMed
LIU X, Makaroff KE, Almario CV, Khalil C, et al Determining patient preferences for the medical management of osteoporosis using
conjoint analysis.
Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06882. PubMedAbstract available
ELWAKIL W, El Gaafary M, El Miedany Y Screening and management of osteoporosis: a survey of knowledge, attitude, and
practice among healthcare professionals in Egypt-a study by the Egyptian Academy
of Bone Health.
Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06914. PubMedAbstract available
CLIFTON GOLDNEY D, Pelegrin C, Jerkovich F, Longobardi V, et al Twenty-four months of follow-up in women with rebound-associated vertebral
fractures after discontinuation of denosumab: a single-centre case series.
Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06894. PubMedAbstract available
LEE RH, Curtis J, Drake MT, Bobo Tanner S 4th, et al Association of prior treatment with nitrogen-containing bisphosphonates on
outcomes of COVID-19 positive patients.
Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06912. PubMedAbstract available
LU K, Wu YM, Shi Q, Gong YQ, et al A novel fracture liaison service using digital health: impact on mortality in
hospitalized elderly osteoporotic fracture patients.
Osteoporos Int. 2023 Sep 12. doi: 10.1007/s00198-023-06905. PubMedAbstract available
NICOLAES J, Liu Y, Zhao Y, Huang P, et al External validation of a convolutional neural network algorithm for
opportunistically detecting vertebral fractures in routine CT scans.
Osteoporos Int. 2023 Sep 7. doi: 10.1007/s00198-023-06903. PubMedAbstract available
PENG T, Zeng X, Li Y, Li M, et al A study on whether deep learning models based on CT images for bone density
classification and prediction can be used for opportunistic osteoporosis
screening.
Osteoporos Int. 2023 Sep 5. doi: 10.1007/s00198-023-06900. PubMedAbstract available
LIU J, Tang Y, Peng B, Tian C, et al Bone mineral density is associated with composite dietary antioxidant index among
US adults: results from NHANES.
Osteoporos Int. 2023 Sep 4. doi: 10.1007/s00198-023-06901. PubMedAbstract available
KARPUZ S Zoledronic acid-induced severe lymphopenia.
Osteoporos Int. 2023;34:1653-1655. PubMedAbstract available
August 2023
MOAYYERI A, Warden J, Han S, Suh HS, et al Estimating the economic burden of osteoporotic fractures in a multinational
study: a real-world data perspective.
Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06895. PubMedAbstract available
WANG J, Xing F, Sheng N, Xiang Z, et al Associations of dietary oxidative balance score with femur osteoporosis in
postmenopausal women: data from the National Health and Nutrition Examination
Survey.
Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06896. PubMedAbstract available
SHAHROUR E A promising strategy for the diagnosis, treatment, and prevention of osteoporosis
(EMS strategy).
Osteoporos Int. 2023 Aug 30. doi: 10.1007/s00198-023-06876. PubMed
BILLINGTON EO, Miyagishima RC, Hasselaar C, Arain M, et al Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic
treatment: a cross-sectional study.
Osteoporos Int. 2023 Aug 22. doi: 10.1007/s00198-023-06890. PubMedAbstract available
BARCELOS A, Goncalves J, Mateus C, Canhao H, et al Costs of incident non-hip osteoporosis-related fractures in postmenopausal women
from a payer perspective.
Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06881. PubMedAbstract available
HONG N, Shin S, Lee S, Rhee Y, et al Romosozumab is associated with greater trabecular bone score improvement compared
to denosumab in postmenopausal osteoporosis.
Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06889. PubMedAbstract available
ABDALBARY M, El-Husseini A Author response to: Comment on: Abdalbary et al. Impact of urinary calcium
excretion on kidney, bone, and cardiovascular systems in patients with bone
biopsy proven osteoporosis: a longitudinal long-term follow-up study.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06874. PubMed
TURABI RY, Sheehan KJ Response letter to: "The importance of structural barriers of osteoporotic hip
fracture in the elderly".
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06864. PubMed
MARTINS MJ Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone,
and cardiovascular systems in patients with bone biopsy proven osteoporosis: a
longitudinal long-term follow-up study. Osteoporos Int. 2023 Apr;34(4):763-774.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06873. PubMed
MEIJIDE H, Gredilla I, Cachorro I, Robert I, et al The importance of structural barriers of osteoporotic hip fracture in the
elderly.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06875. PubMed
LI W, Zhao H, Zhou S, Xiong Z, et al Does vertebral osteoporosis delay or accelerate lumbar disc degeneration? A
systematic review.
Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06880. PubMedAbstract available
KANIS JA, Johansson H, McCloskey EV, Liu E, et al Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
Osteoporos Int. 2023 Aug 11. doi: 10.1007/s00198-023-06870. PubMedAbstract available
SEO DH, Jeong Y, Cho Y, Kim SH, et al Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture
in older adults.
Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06879. PubMedAbstract available
FITZPATRICK D, Seebah S, Lannon R, Mc Carroll K, et al Atypical femoral fracture after denosumab for the treatment of osteoporosis in
bisphosphonate naive patients: two further cases.
Osteoporos Int. 2023 Aug 1. doi: 10.1007/s00198-023-06869. PubMed
July 2023
HE D, Liu H, Wei W, Zhao Y, et al A longitudinal genome-wide association study of bone mineral density mean and
variability in the UK Biobank.
Osteoporos Int. 2023 Jul 27. doi: 10.1007/s00198-023-06852. PubMedAbstract available
THERKILDSEN J, Rohde PD, Nissen L, Thygesen J, et al A genome-wide genomic score added to standard recommended stratification tools
does not improve the identification of patients with very low bone mineral
density.
Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06857. PubMedAbstract available
EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al Comparison of anti-fracture effectiveness of zoledronate, ibandronate and
alendronate versus denosumab in a registry-based cohort study.
Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06863. PubMedAbstract available
MAZEDA C, Barcelos A Gender differences in osteoporosis.
Osteoporos Int. 2023 Jul 20. doi: 10.1007/s00198-023-06858. PubMed
TAN EH, Robinson DE, Jodicke AM, Mosseveld M, et al Drug utilization analysis of osteoporosis medications in seven European
electronic health databases.
Osteoporos Int. 2023 Jul 12. doi: 10.1007/s00198-023-06837. PubMedAbstract available
SCHUMM AK, Craige EA, Arora NK, Owen PJ, et al Does adding exercise or physical activity to pharmacological osteoporosis therapy
in patients with increased fracture risk improve bone mineral density and lower
fracture risk? A systematic review and meta-analysis.
Osteoporos Int. 2023 Jul 11. doi: 10.1007/s00198-023-06829. PubMedAbstract available
HASEGAWA T Author response to OSIN-D-23-00510, "Comment on: A multicenter retrospective
study of the risk factors associated with medication-related osteonecrosis of the
jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can
primary wo
Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06835. PubMed
SOMAY E Comment on: A multicenter retrospective study of the risk factors associated with
medication-related osteonecrosis of the jaw after tooth extraction in patients
receiving oral bisphosphonate therapy: can primary wound closure and a drug
holiday really
Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06821. PubMed
JAVAID MK, Pinedo-Villanueva R, Shah A, Mohsin Z, et al The Capture the Fracture(R) Partnership: an overview of a global initiative to
increase the secondary fracture prevention care for patient benefit.
Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06759. PubMedAbstract available
SHEVROJA E, Reginster JY, Lamy O, Al-Daghri N, et al Update on the clinical use of trabecular bone score (TBS) in the management of
osteoporosis: results of an expert group meeting organized by the European
Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and
Musculoskeletal Dis
Osteoporos Int. 2023 Jul 1. doi: 10.1007/s00198-023-06817. PubMedAbstract available
June 2023
SCHOUSBOE JT, Binkley N, Leslie WD Liver enzyme inducing anticonvulsant drug use is associated with prevalent
vertebral fracture.
Osteoporos Int. 2023 Jun 28. doi: 10.1007/s00198-023-06820. PubMedAbstract available
MOON RJ, Reginster JY, Al-Daghri NM, Thiyagarajan JA, et al Real-world evidence: new opportunities for osteoporosis research. Recommendations
from a Working Group from the European Society for Clinical and Economic Aspects
of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Osteoporos Int. 2023 Jun 23. doi: 10.1007/s00198-023-06827. PubMedAbstract available
KADRI A, Binkley N, Hernando D, Anderson PA, et al Author response to letter to editor: OSIN-D-23-00474, "letter to the editor
regarding 'Opportunistic use of lumbar magnetic resonance imaging for
osteoporosis screening'".
Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06808. PubMed
PU X, Li H Letter to the editor regarding "Opportunistic Use of Lumbar Magnetic Resonance
Imaging for Osteoporosis Screening".
Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06801. PubMed
LIU FC, Luk KC, Chen YC Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with
bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study
in Taiwan.
Osteoporos Int. 2023 Jun 16. doi: 10.1007/s00198-023-06818. PubMedAbstract available
HUANG G, Chen X, Chen Y, Liu W, et al Causal relationship between type 2 diabetes mellitus and bone mineral density: a
Mendelian randomization study in an East Asian population.
Osteoporos Int. 2023 Jun 12. doi: 10.1007/s00198-023-06807. PubMedAbstract available
PASKINS Z, Moult A, Corp N, Bastounis A, et al Research priorities regarding the use of bisphosphonates for osteoporosis: a UK
priority setting exercise.
Osteoporos Int. 2023 Jun 9. doi: 10.1007/s00198-023-06806. PubMedAbstract available
HESARI E, Sanjari M, Mansourzadeh MJ, Fahimfar N, et al Osteoporosis medication adherence tools: a systematic review.
Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06789. PubMedAbstract available
HAGINO H, Moriwaki K, Wada T, Osaki M, et al Urinary pentosidine level is associated with the risk of fracture in
community-dwelling older adults: a prospective observational study.
Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06816. PubMedAbstract available
KUNIHARA T, Tohmori H, Tsukamoto M, Kobayashi M, et al Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from
2016 to 2020 in Kure, Japan.
Osteoporos Int. 2023;34:1101-1109. PubMedAbstract available
May 2023
LIN SM, Lin JY, Tu YK, Wu CH, et al Association between bisphosphonate use and stroke risk: a meta-analysis.
Osteoporos Int. 2023 May 30. doi: 10.1007/s00198-023-06781. PubMedAbstract available
LU K, Wu YM, Shi Q, Gong YQ, et al The impact of acute-phase reaction on mortality and re-fracture after zoledronic
acid in hospitalized elderly osteoporotic fracture patients.
Osteoporos Int. 2023 May 29. doi: 10.1007/s00198-023-06803. PubMedAbstract available
GOLD LS, Suri P, O'Reilly MK, Kallmes DF, et al Mortality among older adults with osteoporotic vertebral fracture.
Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06796. PubMedAbstract available
ZHU K, Hunter M, James A, Lim EM, et al Relationships between longitudinal changes in body composition and bone mineral
density in middle-to-older aged Australians.
Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06773. PubMedAbstract available
LAI SW Adipopenia associated with osteoporosis.
Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06797. PubMed
KWON H, Han KD, Kim BS, Moon SJ, et al Acromegaly and the long-term fracture risk of the vertebra and hip: a national
cohort study.
Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800. PubMedAbstract available
RASHIDI MM, Saeedi Moghaddam S, Azadnajafabad S, Heidari-Foroozan M, et al Low bone mineral density, a neglected condition in North Africa and Middle East:
estimates from the Global Burden of Disease Study, 1990-2019.
Osteoporos Int. 2023 May 23. doi: 10.1007/s00198-023-06778. PubMedAbstract available
KONDAPALLI AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al Clinical characteristics of pregnancy and lactation associated osteoporosis: An
online survey study.
Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06793. PubMedAbstract available
YANG H, Bai J, Li L, Yang Y, et al Association of C-peptide level with bone mineral density in type 2 diabetes
mellitus.
Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06785. PubMedAbstract available
AGARWAL AR, Cohen JS, Tarawneh OH, Gu A, et al The impact of prior fragility fractures on long-term periprosthetic fracture risk
following total knee arthroplasty.
Osteoporos Int. 2023 May 11. doi: 10.1007/s00198-023-06746. PubMedAbstract available
AVGERINOU C, Petersen I, Clegg A, West RM, et al Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and
fragility fractures in people aged 50 years and above: retrospective cohort study
using UK primary care data.
Osteoporos Int. 2023 May 10. doi: 10.1007/s00198-023-06739. PubMedAbstract available
METRAILLER A, Hans D, Lamy O, Gonzalez Rodriguez E, et al Heel quantitative ultrasound (QUS) predicts incident fractures independently of
trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus
Study.
Osteoporos Int. 2023 May 8. doi: 10.1007/s00198-023-06728. PubMedAbstract available
April 2023
HO-PHAM LT, Nguyen HG, Nguyen-Pham SQ, Hoang DK, et al Longitudinal changes in bone mineral density during perimenopausal transition:
the Vietnam Osteoporosis Study.
Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06757. PubMedAbstract available
RISKA BSL, Gunnes N, Stigum H, Finnes TE, et al Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip
fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis
Studies (NOREPOS).
Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06752. PubMedAbstract available
MOON RJ, Green HD, D'Angelo S, Godfrey KM, et al The effect of pregnancy vitamin D supplementation on offspring bone mineral
density in childhood: a systematic review and meta-analysis.
Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06751. PubMedAbstract available
BENNETT MJ, Center JR, Perry L Exploring barriers and opportunities to improve osteoporosis care across the
acute-to-primary care interface: a qualitative study.
Osteoporos Int. 2023 Apr 24. doi: 10.1007/s00198-023-06748. PubMedAbstract available
HILL EC, O'Donnell L Low bone mineral density is associated with fatty liver disease and respiratory
illness in a pediatric mortality sample.
Osteoporos Int. 2023 Apr 21. doi: 10.1007/s00198-023-06760. PubMedAbstract available
CHANG CM, Chen YC, Wu WT, Lin TK, et al Association between clinical use of nifedipine and the risk of osteoporosis: a
nationwide retrospective cohort study.
Osteoporos Int. 2023 Apr 20. doi: 10.1007/s00198-023-06756. PubMedAbstract available
HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al Correction to: A multicenter retrospective study of the risk factors associated
with medication-related osteonecrosis of the jaw after tooth extraction in
patients receiving oral bisphosphonate therapy: can primary wound closure and a
drug holiday rea
Osteoporos Int. 2023 Apr 13. doi: 10.1007/s00198-023-06745. PubMed
PONZANO M, Tibert N, Brien S, Funnell L, et al Publisher Correction: International consensus on the non-pharmacological and
non-surgical management of osteoporotic vertebral fractures.
Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06717. PubMed
ICONARU L, Charles A, Baleanu F, Moreau M, et al Selection for treatment of patients at high risk of fracture by the short versus
long term prediction models - data from the Belgian FRISBEE cohort.
Osteoporos Int. 2023 Apr 6. doi: 10.1007/s00198-023-06737. PubMedAbstract available
KHAN AA, AbuAlrob H, Al-Alwani H, Ali DS, et al Post hip fracture orthogeriatric care-a Canadian position paper addressing
challenges in care and strategies to meet quality indicators.
Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-022-06640. PubMedAbstract available
TANG Y, Zhang L, Ye D, Zhao A, et al Causal relationship between Type 1 diabetes and osteoporosis and fracture
occurrence: a two-sample Mendelian randomization analysis.
Osteoporos Int. 2023 Apr 3. doi: 10.1007/s00198-023-06734. PubMedAbstract available
MATTICK LJ, Bea JW, Hovey KM, Wactawski-Wende J, et al Follicle-stimulating hormone is associated with low bone mass in postmenopausal
women.
Osteoporos Int. 2023;34:693-701. PubMedAbstract available
March 2023
LEGRAND A, Autrusseau F, Bandiaky ON, Idiri K, et al Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in
osteoporosis: toward a complementary populational screening tool managed by
dentists?
Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06724. PubMed
NICKEL B, Krueger D, Borchardt G, Andersen L, et al Intraoperative physician assessment of bone: correlation to bone mineral density.
Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06729. PubMedAbstract available
GOEL H, Binkley N, Hans D, Leslie WD, et al Bone density and trabecular bone score to predict fractures in adults aged
20-39 years: a registry-based study.
Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06722. PubMedAbstract available
LIN Z, Shi G, Liao X, Liu W, et al Effect of pulmonary function on bone mineral density in the United States:
results from the NHANES 2007-2010 study.
Osteoporos Int. 2023 Mar 23. doi: 10.1007/s00198-023-06727. PubMedAbstract available
BINKLEY N, Nickel B, Anderson PA Periprosthetic fractures: an unrecognized osteoporosis crisis.
Osteoporos Int. 2023 Mar 20. doi: 10.1007/s00198-023-06695. PubMedAbstract available
BRUHN R, Pedersen AB, Heide-Jorgensen U, Ehrenstein V, et al Epidemiology of male osteoporosis in Denmark (1996-2018).
Osteoporos Int. 2023 Mar 13. doi: 10.1007/s00198-023-06720. PubMedAbstract available
EISMAN JA, Cortet B, Boolell M, Ionescu-Ittu R, et al Fracture risk in women with osteoporosis initiated on gastro-resistant
risedronate versus immediate release risedronate or alendronate: a claims data
analysis in the USA.
Osteoporos Int. 2023 Mar 6. doi: 10.1007/s00198-022-06627. PubMedAbstract available
HANS D, McDermott M, Huang S, Kim M, et al Long-term effect of denosumab on bone microarchitecture as assessed by tissue
thickness-adjusted trabecular bone score in postmenopausal women with
osteoporosis: results from FREEDOM and its open-label extension.
Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06708. PubMedAbstract available
TALEVSKI J, Gianoudis J, Bailey CA, Ebeling PR, et al Effects of an 18-month community-based, multifaceted, exercise program on
patient-reported outcomes in older adults at risk of fracture: secondary analysis
of a randomised controlled trial.
Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06693. PubMedAbstract available
HU J, Li Y, Wang Z, Li X, et al Association of plant-based dietary patterns with the risk of osteoporosis in
community-dwelling adults over 60 years: a cross-sectional study.
Osteoporos Int. 2023 Mar 1. doi: 10.1007/s00198-023-06700. PubMedAbstract available
February 2023
JUNG SY, Cho EB, Han KD, Jung JH, et al Risk of fracture in neuromyelitis optica spectrum disorder and multiple
sclerosis: a nationwide cohort study in South Korea.
Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06715. PubMedAbstract available
HE D, Pan C, Zhao Y, Wei W, et al Exome-wide screening identifies novel rare risk variants for bone mineral
density.
Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06710. PubMedAbstract available
XIAO X, Wu Q Ethnic disparities in fracture risk assessment using polygenic scores.
Osteoporos Int. 2023 Feb 25. doi: 10.1007/s00198-023-06712. PubMedAbstract available
YE C, Lee K, Leslie WD, Lin M, et al Fracture rate increases after immune checkpoint inhibitor treatment: a potential
new immune related adverse event.
Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06690. PubMedAbstract available